Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from IR-Med (IRME).
IR-Med, Inc. has updated its consulting agreements with key executives, increasing monthly compensation for Interim CEO and CTO Aharon Klein to NIS 35,000 including car expenses, and setting Chief Scientific Officer Dr. Yaniv Cohen’s monthly pay at NIS 15,000. These changes, effective from June 1, 2024, adjust the original agreements made back in 2019, keeping other compensation and equity terms the same.
For a thorough assessment of IRME stock, go to TipRanks’ Stock Analysis page.
